Experimental evidence indicates that loss of BMAL1 or CLOCK function impairs glucose tolerance, alters NAD+/SIRT1 signaling, and disturbs lipid homeostasis, highlighting the molecular link between circadian clock disruption and metabolic disease [6]. The gene discussed is CLOCK; the disease is metabolic disease.